Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 74,000 shares at $6.27 ($477K) on 2023-07-06, disclosed to the SEC on 2023-07-06.
Open-market sale of $477k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.64 | 10,000 | $66K | 13.9% |
| 2 | $6.55 | 16,171 | $106K | 22.2% |
| 3 | $6.55 | 16,171 | $106K | 22.2% |
| 4 | $6.27 | 15,829 | $99K | 20.8% |
| 5 | $6.27 | 15,829 | $99K | 20.8% |
| Total | $6.44 avg | 74,000 |
| $477K |
| 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |